{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-152363","form_type":"8-K","ticker":"SNSE","cik":"0001829802","company_name":"Sensei Biotherapeutics, Inc.","filed_at":"2024-06-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.492540+00:00","generated_at":"2026-06-01T06:53:50.145671+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"low","headline":"Sensei Biotherapeutics updates corporate presentation for investor meetings","bullets":["Filed an updated corporate presentation on June 3, 2024 under Regulation FD.","Presentation used in meetings with investors but no specific new data disclosed.","No financial results, pipeline updates, or clinical milestones included in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-152363","json":"https://secwatch.observer/filing/0001193125-24-152363.json","markdown":"https://secwatch.observer/filing/0001193125-24-152363.md","text":"https://secwatch.observer/filing/0001193125-24-152363.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1829802/000119312524152363/0001193125-24-152363-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1829802/000119312524152363/d845171d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T06:53:50.145671+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}